Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Hande Bio-Tech is a China-based pharmaceutical manufacturer focused on active pharmaceutical ingredients, particularly taxane-based oncology products. Founded in 1993 and based in Kunming/Anning, Yunnan, the company is best known as a producer of paclitaxel API and related intermediates, with additional products including cabazitaxel, 10-deacetylbaccatin III, cepharanthine, melatonin, ecdysterone, and selected ginsenosides. The company appears to operate primarily as a commercial-stage API supplier and manufacturing partner rather than as a drug developer with a traditional clinical pipeline. Publicly available profiles emphasize its GMP manufacturing capabilities and regulatory credentials including references to US FDA, CEP/EDQM, and Chinese GMP compliance. Its commercial reach appears to span North America, Europe, and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Hande Bio-Tech.